Skip to main content

UBS Group AG

Position in CANF — Can-Fite BioPharma Ltd.

CIK 1610520 ZURICH, V8

Position in CANF

as of Mar 31, 2026 · filed May 5, 2026
Position Value
$6,671
+$2,483 QoQ
Shares Held
2,152
+105.5% QoQ
Ownership
0.100%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
13 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in CANF Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS Group AG holds $8,789,681,375 across 562 Biotechnology names.

# Ticker Company Shares Value (USD) Open

All Filings in CANF

Export CSV
13 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $6,671 2,152
2025-12-31 $4,188 20,942
2025-09-30 $810 1,308
2025-06-30 $5,790 5,515
2024-03-31 $4,821 2,172
2023-03-31 $1,635 714
2022-12-31 $5,314 8,712
2022-09-30 $13,368 17,362
2022-06-30 $6,919 7,521
2022-03-31 $8,904 7,181
2021-06-30 $17,576 7,709
2020-06-30 $6,062 3,062
2020-03-31 $11,251 8,589